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human skin by ex vivo TOF-SIMS imaging
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Abstract
Fatty acids classified as chemical penetration enhancers (CPEs) might cause the fluidization and perturbation of
stratum corneum (SC) lipid matrix. The penetration of oleic, linoleic, lauric and capric acids into human skin was
studied by time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging and related to fatty acids enhancing
effect on lipophilic model drug tolnaftate penetration into human epidermis and dermis ex vivo. Fatty acid
enhancing effect on tolnaftate penetration into human skin was evaluated using Bronaugh-type flow-through
diffusion cells. After in vitro penetration studies visualization and spatial localization of fatty acid molecules in
human skin were performed using TOF-SIMS. Penetration of oleic, linoleic, lauric and capric acids into human skin
was compared to the control skin sections by ion images and intensity profiles. Only oleic acid significantly (P<0.05)
enhanced tolnaftate penetration into epidermis (enhancing ratio equal to 1.867). CPE might have no effect on
model drug penetration enhancement, but might penetrate itself into the skin.
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Background
Stratum corneum (SC), composed of corneocytes and
extracellular lipid matrix, is recognized as the main bar-
rier layer for passive diffusion of drug molecules into
and through the skin. Knowledge about SC lipid
organization allows for better understanding and inter-
pretation of low permeability of drugs through SC and
the modes of chemical penetration enhancers (CPEs) ac-
tion. Fatty acids belong to lipophilic CPEs which might
cause the reorganization of SC lipid matrix, thus the
prerequisite for fatty acid enhancing effect on drug per-
meation would be its penetration into the skin and
following disruption of skin lipids arrangement.
SC lipid matrix is mainly composed of neutral lipids:
ceramides (CER), cholesterol (CHOL) and free fatty
acids (FFA) [1] in an approximate molar ratio 3:2:1 [2].
FFAs, naturally present in the SC, predominantly have
saturated and straight chains of 22 (docosanoic acid), 24
(lignocerin acid) and 26 (hexacosanoic acid) carbon
atoms [3,4]. Oleic and linoleic acids are the only unsat-
urated fatty acids detected in SC [5]. Freeze-fracture
[6,7] and ruthenium tetroxide post-fixation [8] electron
microscopy studies revealed that lipids are arranged into
bilayers [9,10]. Lipid chains tend to pack in tight lateral
highly ordered packing (according to packing density:
liquid < hexagonal (gel) < orthorhombic (crystalline)
phases), which has been studied using atomic force mi-
croscopy [11], Fourier transformed infrared spectroscopy
[12], wide-angle X-ray diffraction [13] and electron dif-
fraction [14]. All three phases coexist, but it is believed
that conformationally ordered orthorhombic packing of
lipids is mainly responsible for the resistance to trans-
dermal delivery of molecules [15].
Small-angle X-ray diffraction [16-18] and electron mi-
croscopy [19,20] studies demonstrated that two lamellar
structures, namely long and short periodicity phases
(LPP and SPP, respectively), are characteristic to lamellar
ordering of lipid bilayers [21]. Lipid lamella is oriented
in parallel to corneocyte surface and its LPP has a repeat
distance of 13 nm and SPP – of 6 nm [22]. LPP is orga-
nized in trilamellar repeat units of broad-narrow-broad
electron lucent bands [23] and is considered to highly
impact SC barrier properties. Several theoretical SC lipid
model systems were proposed in order to describe the
ordering of lipids in lamella. These models, such as the
stacked monolayer model (proposed by Swartzendruber
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et al., 1989 [20]), the domain mosaic model (Forslind,
1994 [24]), the sandwich model (Bouwstra et al., 2000
[18]) and single gel phase model (Norlen, 2001 [25])
comprise the architecture of lipid molecules arrange-
ment and the phase behaviour of lipid matrix [26,27].
Lamellar but not lateral lipid organization is dependent
on pH [28], thus pH is also maintaining human skin
barrier capacity and is in the range of 4.0-5.5 [29].
Well-defined SC lipid composition, organization and
phase behaviour of extracellular matrix allow for better
interpretation of CPE interactions with lipid molecules.
In order to relate the penetration of oleic, linoleic,
lauric and capric fatty acids and their enhancing effect
on lipophilic model drug penetration into human skin
ex vivo, two techniques were applied: in vitro skin
penetration studies and mass spectrometry imaging
(MSI). In vitro skin penetration studies were carried
out using Bronaugh-type flow-through diffusion cells.
Donor solutions containing model drug and CPE
dissolved were applied to the skin surface for 12 h.
Model drug was quantified in skin layers using a
validated HPLC-UV method. The enhancing ratio of
fatty acid on model drug’s penetration was calculated.
In order to demonstrate the penetration of CPE into
human skin, MSI was applied after in vitro skin pene-
tration studies. Among the various techniques aiming
to map the surface of the sample, MSI is the only
analytical method capable of providing in a single run
the spatial distribution of a wide range of molecules
over the surface of a biological sample [30]. Time-of
-flight secondary ion mass spectrometry (TOF-SIMS)
is a technique of choice for MSI and to our knowledge
there is no published data on any attempts to visualize
exogenously applied fatty acids penetration and distri-
bution in human skin till now. This technology
consists of the bombardment of the sample by a beam
of mono- or polyatomic ions, which induce desorption/
ionization of secondary ions from the sample surface
[31-35]. It also offers the possibility to localize various
molecules, mainly lipids and metabolites, with a mass-
to-charge ratio up to m/z 1000–1500 and a lateral
resolution from 400 nm to 1–2 μm, which makes the
technology particularly efficient for the analysis of
tissue sections. The field of research of TOF-SIMS
imaging is then rapidly expanding and more widely
used in many applications, mainly in biological
sciences and medicine [36-39]. In the present work, we
have used TOF-SIMS imaging in order to visualize and
evaluate the penetration of externally applied fatty
acids into human skin.
As enhancing effect of fatty acids was investigated, a
lipophilic model drug with appopriate physicochemical
properties ensuring its penetration via lipoidal route had
to be chosen. A thiocarbamate antifungal drug tolnaftate
was selected as a model compound for in vitro skin pene-
tration experiments. High hydrophobicity (XLogP = 5.5),
low molecular weight (307.4 Da) and melting point of
109-112°C (Eur. Pharm. 6.0; 01/2008:1158) are physi-
cochemical properties which ensure tolnaftate’s capability
of passive diffusion through SC via lipoidal intercellular
route and accumulation in superficial layers of skin.





thiocarbamate; Eur. Pharm. 6.0; purity of 99.7%) was
obtained from pharmaceutical company Sanitas AB
(Kaunas, Lithuania) as a gift. Polyethylene glycol 400
(PEG 400) was purchased from Carl Roth GmbH
(Karlsruhe, Germany). Capric acid (decanoic acid) was
obtained from Merck Schuchardt OHG (Hohenbrunn,
Germany). Oleic acid (cis-9-octadecenoic acid) and
methanol (ChromasolvW) were purchased from Sigma-
Aldrich Chemie GmbH (Steinheim, Germany). Linoleic
acid (cis, cis-9,12-octadecadienoic acid) and lauric acid
(dodecanoic acid) were purchased from Alfa Aesar
GmbH (Karlsruhe, Germany). Sodium azide (NaN3) was
obtained from POCh (Gliwice, Poland). Ethanol (96.3%)
was obtained from Stumbras AB (Kaunas, Lithuania).
All other reagents were of analytical grade.
Human skin preparation
Studies with human skin were approved by Kaunas
Region Bioethical Committee. Caucasian women’s (of
age 25–40) abdominal skin was obtained after excision
in the Department of Plastic and Reconstructive Surgery,
Hospital of Lithuanian University of Health Sciences
Kaunas Clinics, appropriately treated and stored at −20°C
for not longer than 6 months before use.
Equipment
In vitro skin penetration experiments were carried out
using teflon-made Bronaugh-type flow-through diffusion
cells. Acceptor medium was circulated by peristaltic
pump (MasterflexW L/SW, Cole-Parmer Instrument Co.,
Illinois, USA). Extraction of skin layers was performed
using Bandelin Sonorex Digitec Ultrasonic Bath (DT
156, Bandelin electronic GmbH & Co. KG, Berlin,
Germany).
HPLC analysis was carried out using Shimadzu Liquid
Chromatograph (Shimadzu Corporation, Kyoto, Japan)
coupled with UV–vis detector.
Preparation of the donor phase
The donor solutions for in vitro skin penetration
experiments were prepared by dissolving tolnaftate (1%,
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w/w) in PEG 400 and following addition of oleic, lino-
leic, lauric or capric acid to comprise 10% (w/w) of total
amount. If necessary, slight heating (up to 50°C) was
employed. Tolnaftate 1% (w/w) solution in PEG 400 was
used as control.
In vitro skin penetration experiments
Full-thickness human skin was mounted into Bronaugh-
type flow-through diffusion cells (diffusional area
0.64 cm2). 37±1°C was maintained in temperature con-
trolled block, holding the cells. 12 h equilibration period
was followed circulating 0.9% NaCl+0.005% NaN3
underneath the skin. Infinite dose (approximately
200 mg) of donor solutions was applied on the SC side
of the skin surface for another 12 h. The acceptor fluid
(4 mL 0.9% NaCl+0.005% NaN3) was pumped at a rate
of 0.6 mL/min and was entirely replaced after 4 and 8 h.
After 12 h the donor phase was carefully removed and
the skin surface was rinsed with ethanol (96.3%) and
then 0.9% NaCl.
After in vitro skin penetration experiment skin
specimens were analyzed for tolnaftate content in epi-
dermis and dermis separately, using a validated HPLC
method [40], or were frozen and subjected to TOF-SIMS
imaging analysis.
HPLC analysis of human skin layers for model drug
content
After in vitro skin penetration experiments epidermis
was separated from dermis using dry heat separation
method [41]. Separated layers were extracted with
methanol, following bath sonication for 30 min. The
supernatant was filtered through nylon membrane filter
(0.45 μm, Carl Roth GmbH, Karlsruhe, Germany) and
injected into HPLC.
Separation of tolnaftate from endogenous compounds
of skin matrix was accomplished on a LiChrospherW100
RP-18 Endcapped column, 125 × 4 mm, i.d., packed with
5 μm size particles (Merck KGaA, Darmstadt, Germany)
and maintained at 40°C. A LiChrospher 100 RP-18e
(5 μm) (LiChroCART 4–4) was used as a guard column.
The flow rate of the mobile phase (70% methanol and
30% bi-distilled water) was 0.8 mL/min and the injec-
tion volume was 10 μL. Tolnaftate detection was set
at λ = 257 nm.
TOF-SIMS imaging of human skin sections for CPE
penetration visualization and ion imaging
Circle full-thickness skin specimens, obtained after
in vitro skin penetration experiments, were immediately
frozen at −60°C and stored until cryosectioning proce-
dure. Skin specimens were embedded in OCT medium
and sections of 12 μm thick were cut at −20°C using a
CM3050-S cryostat (Leica Microsystèmes SA, Nanterre,
France) and immediately deposited on a silicon wafer
(2-in.-diameter polished silicon wafers, ACM, Villiers-
Saint-Frédéric, France). The samples were dried under
vacuum at a pressure of a few hectopascals for 15 min
before analysis. Optical images were recorded with an
Olympus BX51 microscope (Olympus, Rungis, France)
equipped with lenses ×1.25 to ×50 and a ColorView
I camera, monitored by CellB software (Soft Imaging
System, GmbH, Münster, Germany).
The experiments were performed using a commercial
TOF-SIMS IV time-of-flight mass spectrometer (ION-
TOF GmbH, Münster, Germany), located at the Institut de
Chimie des Substances Naturelles (CNRS, Gif-sur-Yvette,
France). The spectrometer is equipped with a liquid metal
ion gun (LMIG) filled with bismuth. Bi3
+ cluster ions were
selected for all experiments. Primary ions extracted from
the source emitted with a 25 kV potential reach the sam-
ple surface with a kinetic energy of 25 keV and at angle of
incidence of 45°. Secondary ions are accelerated to an
energy of 2 keV, fly through a field free region, and are
reflected with a single stage reflector (effective flight path
~ 2 m) before being post accelerated to 10 keV just before
hitting the entrance surface of the hybrid detector, which
is made of one single micro-channel plate, followed by a
scintillator and a photomultiplier. A low-energy electron
flood gun is activated between two primary ions pulses in
order to neutralize the sample surface with the minimum
damage [42].
Only one mode of operation of the primary ion co-
lumn has been used during the experiments, which is
called ‘high-current bunched mode’ [43,44], thus provi-
ding both a beam focus of 2 μm and a pulse duration of
a less 1 ns. Such experimental conditions enabled an ex-
cellent mass resolution, M/ΔM = 8000 (full width at half
maximum, FWHM), at m/z 500. The Bi3
+ primary ion
current, measured at 10 kHz with a Faraday cup on the
grounded sample holder, is ~0.65 pA in the high-current
bunched mode. For images of human skin sections, a
large-area analysis (1.5 mm × 0.5 mm) was performed
using these same LMIG conditions, i.e. high-current
bunched mode, and the so-called stage scan. In this case,
the sample is moved step by step to record three succes-
sive patches of 0.5 mm × 0.5 mm each. The number of
pixel was 750 × 250, each pixel having a size 2 × 2 μm2.
Under these conditions, the fluence (also called primary
ion dose density) is maintained to 5 × 1011 ions/cm2,
which is below the so-called static SIMS limit [45].
Because of the very low kinetic energy distribution of
the secondary ions, the relationship between the time-of
-flight and the square root of m/z is always linear over
the whole mass range. The calibration was always in-
ternal, and signals used for initial calibration were those
of H-, C-, CH-, CH2
- , C2
- , C3
- , and C4H
- for the negative
ion mode.
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The data acquisition and processing software was
SurfaceLab 6.2 (ION-TOF GmbH, Münster, Germany).
Statistical analysis
For the statistical analysis, one-way analysis of variance
(ANOVA) together with Tukey’s HSD test were applied
using SPSS software. The level of significance was deter-
mined as P<0.05.
Results
Effect of fatty acids on tolnaftate penetration into
epidermis
The amounts of tolnaftate (T) (μg/cm2, n=3) penetrating
into epidermis from control solution and 10% (w/w)
fatty acid solutions during 12 h of in vitro skin penetra-
tion experiments were assessed by HPLC-UV and are
presented in Table 1. The enhancing effect of fatty acid
on tolnaftate penetration into 1 cm2 of epidermis (E)
was expressed as the enhancing ratio (ER) and calculated
using the following formula:
ER ¼
T amount in E from formulation
with fatty acid μg=cm2ð Þ
T amount in E from control formulation μg=cm2ð Þ
The obtained ER values are presented in Table 1.
ANOVA revealed that tolnaftate amount penetrating
into 1 cm2 of epidermis from the solution containing
oleic acid was significantly greater (P<0.05) than from
the control solution. Linoleic, lauric and capric acids did
not significantly enhance tolnaftate penetration into epi-
dermis comparing to the control.
Tolnaftate was not penetrating into hydrophilic dermis
(only traces below limit of quantitation were found) and
no drug was detected in the acceptor fluid.
TOF-SIMS imaging of fatty acids penetration into human
skin
Human skin sections were analyzed by TOF-SIMS ima-
ging to demonstrate the penetration of fatty acids into
skin. Fatty acids are labeled (CX:Y), which specifies the
number of carbon atoms (X) and double bonds (Y) in
the molecule. Figure 1 shows a typical mass spectrum
recorded in the negative ion mode. This spectrum is
dominated by lipid ion peaks, mainly fatty acids. The
most intense ion peaks together with their formula are
listed in Table 2. Human skin sections in depth of
1500 μm contained whole epidermis and part of dermis.
Indeed, the epidermis layer is about 100 μm, while the
dermis is about 1000 μm in thickness. On the other
hand, during the skin penetration studies hydrophilic
dermis gets swollen due to acceptor medium, circulated
underneath the skin.
Together with optical images of the sections, Figure 2
shows ion images corresponding to the spatial localization
of [M-H]- carboxylate ions of capric acid C10:0 (m/z
171.10, top left), lauric acid C12:0 (m/z 198.96, top right),
linoleic acid C18:2 (m/z 279.28, bottom left), and oleic
acid C18:1 (m/z 281.29, bottom right), in human skin
treated with 10% fatty acid solution (b, e, h and k, respec-
tively) and control (c, f, i and l, respectively). The ion
images for each fatty acid have been normalized according
to the higher mc value, in order to allow for direct com-
parison. For all these figures, optical images (a, d, g and j)
are those of human skin sections corresponding to the ion
images (b, e, h and k). TOF-SIMS analyses were repeated
in triplicate for each fatty acid exposed tissue in order to
confirm the analytical repeatability and the biological
reproducibility (Additional file 1: Figure S1).
TOF-SIMS imaging revealed that lauric (Figure 2e)
and oleic (Figure 2k) acids significantly penetrate into
human skin comparing to the control (Figure 2f and
Figure 2l, respectively). Capric (Figure 2b) and linoleic
(Figure 2h) acids show a penetration into the skin
sections (Figure 2c and Figure 2i, respectively), which is
not as significant as for lauric and oleic acids. These
relative variations of concentration as a function of
Table 1 Amount of tolnaftate in human epidermis
quantified by a validated HPLC-UV method, and
enhancing ratios of fatty acids
Donor phase T amount, μg/cm2 ± SD,
n=3 (epidermis)
ER (epidermis)
Control solution 2.56 ± 0.15 -
With 10% oleic acid 4.77 ± 0.79 1.86٭
With 10% linoleic acid 2.61 ± 0.32 1.02
With 10% lauric acid 3.06 ± 0.32 1.20
With 10% capric acid 2.42 ± 0.40 0.95
Abbreviations: T, tolnaftate; ER, enhancing ratio.
٭Siginificant difference at P < 0.05.
Figure 1 TOF-SIMS negative ion mass spectrum of fatty acids at
the surface of a human skin section.
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depth are not obviously observed directly from the
images shown in Figure 2, particularly because the skin
sections are not exempt from holes or lipid droplets.
That is the reason why intensity profiles, as a function of
depth, have been drawn from each of these fatty acid ion
images (Figure 3). These intensity profiles are shown by
a black solid line in the case of fatty acid exposed, and
red solid line for the control. These profiles show the in-
tensity of a specific ion species, over the whole analysed
depth, and integrated over the entire width of the
images. The results, which are presented in Figure 3, are
from the same data acquisition as of Figure 2. If the solid
black line lies above the red one, it could be concluded
that the corresponding fatty acid penetrates into the skin
layers. It is clear from this figure that capric, oleic, lino-
leic and lauric acids did penetrate into skin when
compared to the control. Furthermore, the lauric acid
shows a high accumulation into the dermis when
compared to the control. It must be noted that there is
not comparable ion image corresponding to the tol-
naftate drug molecule, because this active compound
was not detected by TOF-SIMS imaging.
Discussion
Combination of in vitro skin penetration method and
TOF-SIMS imaging allowed relating the CPE effect on
model drug diffusion into the skin during 12 h experi-
ment with enhancer capability to enter the skin layers.
The diffusion cell method is a reliable method for
measuring drug transport into/across the skin. In our
studies, human skin was obtained from the same donor,
thus inter-individual variance was reduced and the
coefficients of variation (CV) were lower than 16.6%
(calculations made after determination of tolnaftate
levels in skin layers by HPLC).
TOF-SIMS analysis of skin specimens might be
interfered by several factors. Normally, skin surface is
covered by sebum, composed of squalene, wax esters
and triglycerides [28]. Lipases acting on the surface of
SC hydrolyze the sebaceous lipids to FFAs of C16 and
Table 2 Mass-to-charge ratio of the main fatty acid
carboxylate ions detected in the TOF-SIMS spectra in
negative ion mode from the surface of sections from
human skin and their chemical assignments
Fatty acid name M m/z value of the [M-H]- ion
Capric acid C10H20O2 (C10:0) 171.091
Lauric acid C12H24O2 (C12:0) 198.959
Palmitoleic acid C16H30O2 (C16:1) 253.245
Palmitic acid C16H32O2 (C16:0) 255.261
Linoleic acid C18H32O2 (C18:2) 279.264
Oleic acid C18H34O2 (C18:1) 281.275
The labels (CX:Y) specifies the number of carbon atoms (X) and double bonds
(Y) in the ion.
Figure 2 Optical and mass spectrometry images of human skin sections. a, d, g and j: Optical pictures of transversal human skin sections; b,
e, h and k: TOF-SIMS images (negative ion mode) showing lateral distribution of capric, lauric, linoleic and oleic acid ions in skin treated with 10%
fatty acid solution; c, f, i and l: TOF-SIMS images (negative ion mode) showing lateral distribution of capric, lauric, linoleic and oleic acid ions in
control skin. Field of view 1.5 × 0.5 mm2, 750 × 250 pixels, pixel size 2 × 2 μm2, fluence 5 × 1011 ions/cm2. The amplitude of the color scale
corresponds to the maximum number of counts mc and could be read as [0, mc]. tc is the total number of counts recorded for the specified m/z
(the sum of counts in all pixels).
Kezutyte et al. Biointerphases 2013, 8:3 Page 5 of 8
http://www.biointerphases.com/8/1/3
C18 with monounsaturation or branched chains [29].
Lauric and sapienic (C16:1) acids deriving from tri-
glycerides (TGC) and covering the surface of human
skin, are associated with antimicrobial action [46]. Thus
FFAs naturally present on skin surface might affect the
TOF-SIMS analysis of externally applied fatty acids. In
this case SC surface wipe procedures before and after
in vitro skin penetration experiments are important for
validity of results. Cleaning of SC surface with 0.9%
NaCl before in vitro experiments and careful removal of
donor phase followed by rinsing with ethanol and 0.9%
NaCl after in vitro experiments, ensured elimination of
sebum traces from skin surface.
On the other hand, cryosectioning of skin specimens for
TOF-SIMS analysis caused contamination of skin sections
with TGC from subcutaneous fat [29]. The contamination
with lipid droplets was visually observed in microscopic
examination of skin samples and TOF-SIMS analysis
revealed, that in these lipid droplets oleic, linoleic, palmitic
and palmitoleic acids were present. Despite above men-
tioned factors, TOF-SIMS analysis allowed for ion imaging
and evaluation of fatty acid penetration into human skin
after in vitro skin penetration experiments and valuable
and reliable results were obtained.
Lipophilic CPEs cause fluidization and perturbation
of SC lipid matrix as they partition and insert the
hydrophobic tails into highly ordered packing of lipid
bilayers. Differences in CPE head group and CER or
CHOL structure [47] cause disruption of crystalline lipid
packing. Formation of microcavities in SC lipids and
increase of free volume fraction cause the enhancement
of drugs diffusion coefficient [48] and, according to
Fick’s first law of diffusion, promotion of the permeation
of molecules through SC occurs [49].
The enhancing effect of aliphatic acids has a parabolic
dependence on chain length: the maximum effect is
exerted by fatty acids with chain lengths around C12
[50,51]. Lauric acid has a high affinity to skin due to its
optimal partition coefficient and solubility parameter
[52] and it also might acquire a spatial form, which is
conformationally similar to CHOL framework and which
affects the packing of lipids [51]. During 12 h of in vitro
skin penetration experiment, lauric acid penetrated into
human skin from PEG 400 solution, but its enhancing
effect on tolnaftate penetration was not significant.
Kravchenko et al. [51] states, that acids with shorter
chains of less than C11 are not capable to disturb the
packing of lipids in SC, as short chain acids are insuf-
ficiently lipophilic [53]. On the other hand, Nair and
Panchagnula [47] proposed, that C10-C12 chain length
acids disrupt CER-CHOL or CHOL-CHOL interaction
and in this way should increase the permeability of drugs.
Figure 3 Average ion intensities of the different fatty acids as a function of depth in the human skin sections for: top left capric acid
(a), top right lauric acid (b), bottom left linoleic acid (c), bottom right oleic acid (d). Each viewgraph presents a combination of both
experiments: 10% fatty acid in PEG 400 (solid black lines) and control (solid red lines). Note that depth of skin could not be associated to in vivo
conditions as swelling of skin occurs in diffusion cells due to absorption of acceptor medium, circulating underneath the skin sample.
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In our experiments capric acid penetrated into skin, but
probably did not cause rearrangement of lipids and thus
did not significantly enhance the penetration of tolnaftate.
Oleic and linoleic acids are both unsaturated, having
one and two double bonds, respectively. Central location
of double bond conditions the formation of a ‘kink’ [50],
and this is attributed to the most potential CPE – oleic
acid. Oleic acid is considered to create fluid-like phase
within intercellular space [54-57]. In our studies, oleic
acid significantly enhanced tolnaftate penetration into
epidermis (ER=1.867) and its penetration into human
skin was confirmed by TOF-SIMS analysis. Linoleic acid
did not have a significant enhancing effect on tolnaftate
penetration, while its penetration was confirmed by
TOF-SIMS imaging.
Conclusions
TOF-SIMS imaging of oleic, linoleic, lauric and capric
acids in human skin confirmed their penetration. In
addition, only lauric acid indicates a high accumulation
in the dermis. On the other hand, only oleic acid
demonstrated significant enhancing effect on hydrophobic
model drug penetration. Penetration of fatty acid itself
could not be considered as sufficient prerequisite for en-
hancing the penetration of model drug. Differences in
physicochemical properties of fatty acids might determine
their different affinity to skin lipids and mechanisms of ac-
tion, thus their penetration capabilities and enhancing ef-
fect on lipophilic model drug penetration are different.
In order to alter skin barrier properties, CPEs are widely
used in dermatological products as it is a simple and con-
venient way to improve drug’s penetration. It is common
to evaluate the CPE’s effect on drug penetration into the
skin while performing in vitro skin penetration studies.
But if enhancer does not have any effect on drug penetra-
tion, it does not mean that enhancer itself is not pene-
trating into the skin and that no possible toxicity,
pharmacological response or irreversibility of action could
be associated with it. The need of analytical method, sui-
table for fast and reproducible mapping of enhancer di-
rectly on biological tissue without any sample preparation,
might be overcome by using TOF–SIMS imaging.
Additional file
Additional file 1: TOF-SIMS images (negative ion mode) showing
the lateral distribution of capric (top left), lauric (top right), linoleic
(bottom left) and oleic acid (bottom roght) ions in skin treated with
10% fatty acid solution. Field of view 1.5 × 0.5 mm2, 750 × 250 pixels,
pixel size 2 × 2 μm2, fluence 5 × 1011 ions/cm2. The amplitude of the
color scale corresponds to the maximum number of counts mc and
could be read as [0, mc]. tc is the total number of counts recorded for
the specified m/z (the sum of counts in all pixels).
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